Drug Cos. Put Off Planning For Generic Competition
Even with billions of dollars at stake, pharmaceutical companies are surprisingly slow to prepare for the competitive onslaught brought by generic drugs, a new study concludes....To view the full article, register now.
Already a subscriber? Click here to view full article